6W2B image
Deposition Date 2020-03-05
Release Date 2020-03-25
Last Version Date 2024-11-06
Entry Detail
PDB ID:
6W2B
Title:
Anomalous bromine signal reveals the position of Br-paroxetine complexed with the serotonin transporter at the central site
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Mus musculus (Taxon ID: 10090)
Host Organism:
Method Details:
Experimental Method:
Resolution:
4.70 Å
R-Value Free:
0.29
R-Value Work:
0.25
R-Value Observed:
0.26
Space Group:
C 2 2 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Sodium-dependent serotonin transporter
Gene (Uniprot):SLC6A4
Chain IDs:A
Chain Length:549
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:8B6 heavy chain antibody fragment
Chain IDs:B
Chain Length:229
Number of Molecules:1
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Molecule:8B6 light chain antibody fragment
Chain IDs:C
Chain Length:214
Number of Molecules:1
Biological Source:Mus musculus
Primary Citation
Chemical and structural investigation of the paroxetine-human serotonin transporter complex.
Elife 9 ? ? (2020)
PMID: 32618269 DOI: 10.7554/eLife.56427

Abstact

Antidepressants target the serotonin transporter (SERT) by inhibiting serotonin reuptake. Structural and biochemical studies aiming to understand binding of small-molecules to conformationally dynamic transporters like SERT often require thermostabilizing mutations and antibodies to stabilize a specific conformation, leading to questions about relationships of these structures to the bonafide conformation and inhibitor binding poses of wild-type transporter. To address these concerns, we determined the structures of ∆N72/∆C13 and ts2-inactive SERT bound to paroxetine analogues using single-particle cryo-EM and x-ray crystallography, respectively. We synthesized enantiopure analogues of paroxetine containing either bromine or iodine instead of fluorine. We exploited the anomalous scattering of bromine and iodine to define the pose of these inhibitors and investigated inhibitor binding to Asn177 mutants of ts2-active SERT. These studies provide mutually consistent insights into how paroxetine and its analogues bind to the central substrate-binding site of SERT, stabilize the outward-open conformation, and inhibit serotonin transport.

Legend

Protein

Chemical

Disease

Primary Citation of related structures